Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v3.20.1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Income Statement [Abstract]    
Product sales $ 18 $ 437
Operating cost and expense    
Cost of product sales 1,454 4,681
Research and development cost 242 620
General and administrative expense 2,385 4,016
Total operating expense 4,081 9,317
Loss from operations (4,063) (8,880)
Other income and (expense)    
Insurance proceeds net of related expenses (203) 0
Interest expense (183) (2,889)
Interest and other income 22 63
Total other expense, net (364) (2,826)
Loss before income tax expense (4,427) (11,706)
Income tax expense 0 (2)
Net loss $ (4,427) $ (11,708)
Weighted average shares outstanding, basic and diluted (in shares) 59,582,603 43,514,225
Basic and diluted net loss per share (in dollars per share) $ (0.07) $ (0.27)